$TRNS

Transcat, Inc. (NASDAQ:TRNS) Given Consensus Rating of "Hold" by Analysts

Five research firms have issued a consensus "Hold" rating for Transcat, Inc. (NASDAQ:TRNS), with an average 1-year price target of $105.3333. Despite some analysts cutting their ratings, institutional investment in Transcat has increased significantly over recent quarters. The company reported quarterly earnings below consensus but exceeded revenue expectations, with analysts predicting $2.3 EPS for the current fiscal year.

Original reporting
MarketBeat · MarketBeat
Published Apr 11, 2026, 8:33 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 11, 2026, 9:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Transcat, Inc. (NASDAQ:TRNS) Given Consensus Rating of "Hold" by Analysts — source image
Decision brief

The 30-second read

$TRNSNeutralLow
01

Why it matters

The mixed earnings results and stable analyst ratings suggest a cautious outlook, with limited immediate trading opportunities.

02

Market read

The news has limited immediate impact on trading strategies but provides insight into the company's current valuation and institutional interest.

03

What to watch

Potential upcoming earnings reports or industry developments could alter the outlook; monitor for upcoming catalysts.

Timing: Long-term

Background

Transcat, Inc. is a provider of industrial testing equipment and consumables, with recent earnings below consensus but revenue exceeding expectations.

Company-level read

Ticker impact

$TRNSNeutralMedium confidence
Context

The news directly pertains to Transcat, Inc., a NASDAQ-listed company, with a consensus 'Hold' rating and recent earnings report.

Expected impact

Minimal short-term price movement expected; potential sideways trading around current levels.

Evidence & confidence

The consensus rating and mixed earnings results indicate a balanced outlook. Institutional investment increase suggests underlying confidence, but the lack of upward rating upgrades tempers bullish expectations.

Market effects

The industrial and specialized distribution sector may experience slight volatility, but overall impact is limited.

Primarily affects US-based investors; regional effects are minimal.

Low; the news pertains to a US-listed company with limited global influence.

Counterpoint

Some analysts may interpret the increased institutional investment as a sign of underlying confidence, potentially leading to future upgrades.

Key entities

  • Transcat, Inc.

    A provider of industrial testing equipment and consumables.

Related articles

$TRNSMed

Transcat’s (NASDAQ:TRNS) Q2 CY2026: Strong Sales

Transcat (NASDAQ:TRNS) reported Q2 CY2026 results. Revenue rose 21.6% year on year to $92.95 million, topping Wall Street estimates by 7.4%. Non-GAAP adjusted EPS was $0.51, up 35.1% versus analysts’ consensus and down from $0.59 a year earlier. Analysts expect revenue to grow about 6% over the next 12 months.

$TRNSMed

TRANSCAT INC (TRNS): Results of Operations and Financial Condition

TRANSCAT INC (TRNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 trns-20260804xex991.htm EX-99.1 Document Exhibit 99.1 NEWS RELEASE Transcat, Inc. 35 Vantage Point Drive • Rochester • NY • 14624 • Phone: (585) 352-7777 Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growt

$TRNSHighAI 9/10

Transcat Inc (TRNS) Q4 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion

Transcat’s CEO Jaime Irick said he will apply Lean Six Sigma to improve efficiency, cycle times, customer-facing processes, and innovation. CFO Thomas Barbato noted Q4 service gross margins were pressured by new customer onboarding, expecting normalization in fiscal 2027 H1 and year-over-year margin gains for the full year. He reiterated an M&A push into new geographies, citing a Latin America SCM acquisition in Costa Rica and exploring sites in several US regions; rental is expected to grow low

$TRNSHighAI 9/10

Transcat Q4 Earnings Call Highlights

Transcat (NASDAQ:TRNS) reported fiscal Q4 consolidated revenue up 16% to $89.3M and full-year revenue up 19% to $331.9M, according to management on its earnings call. Service revenue rose 18% (7% organic) and marked 68 straight quarters of YoY service growth; service gross margin was 35.5%. Adjusted Q4 EPS was $0.56; full-year adjusted EPS $1.84. Management expects higher service organic growth in fiscal Q1 vs Q4.

$TRNSHighAI 9/10

Full Transcript: Transcat Q4 2026 Earnings Call - Transcat (NASDAQ: TRNS)

Transcat (NASDAQ:TRNS) reported Q4 FY2026 consolidated revenue of $89.3 million, up 16%, and full-year revenue growth of 19%. Service revenue rose 18% in Q4 and 20% for the year, supporting gross profit up 18% and gross margin expansion of 50 bps. Adjusted EBITDA grew 23% for the full year. The company said its SCM Metrology acquisition expands operations into Latin America.